Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
- PMID: 22579660
- DOI: 10.1016/j.pbiomolbio.2012.05.001
Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
Abstract
Current investigation of cancer progression towards increasing malignancy focuses on the molecular pathways that produce the various cancerous traits of cells. Their acquisition is explained by the somatic mutation theory: tumor progression is the result of a neo-Darwinian evolution in the tissue. Herein cells are the units of selection. Random genetic mutations permanently affecting these pathways create malignant cell phenotypes that are selected for in the disturbed tissue. However, could it be that the capacity of the genome and its gene regulatory network to generate the vast diversity of cell types during development, i.e., to produce inheritable phenotypic changes without mutations, is harnessed by tumorigenesis to propel a directional change towards malignancy? Here we take an encompassing perspective, transcending the orthodoxy of molecular carcinogenesis and review mechanisms of somatic evolution beyond the Neo-Darwinian scheme. We discuss the central concept of "cancer attractors" - the hidden stable states of gene regulatory networks normally not occupied by cells. Noise-induced transitions into such attractors provide a source for randomness (chance) and regulatory constraints (necessity) in the acquisition of novel expression profiles that can be inherited across cell divisions, and hence, can be selected for. But attractors can also be reached in response to environmental signals - thus offering the possibility for inheriting acquired traits that can also be selected for. Therefore, we face the possibility of non-genetic (mutation-independent) equivalents to both Darwinian and Lamarckian evolution which may jointly explain the arrow of change pointing toward increasing malignancy.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells.Cancer Metastasis Rev. 2013 Dec;32(3-4):423-48. doi: 10.1007/s10555-013-9435-7. Cancer Metastasis Rev. 2013. PMID: 23640024 Review.
-
Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer.Trends Cancer. 2021 Apr;7(4):309-322. doi: 10.1016/j.trecan.2020.12.007. Epub 2021 Feb 1. Trends Cancer. 2021. PMID: 33536158 Review.
-
Environmental Epigenetics and a Unified Theory of the Molecular Aspects of Evolution: A Neo-Lamarckian Concept that Facilitates Neo-Darwinian Evolution.Genome Biol Evol. 2015 Apr 26;7(5):1296-302. doi: 10.1093/gbe/evv073. Genome Biol Evol. 2015. PMID: 25917417 Free PMC article. Review.
-
An evolutionary model of carcinogenesis.Cancer Res. 2003 Oct 1;63(19):6212-20. Cancer Res. 2003. PMID: 14559806
-
The Yin and Yang of anti-Darwinian epigenetics and Darwinian genetics.Riv Biol. 2007 Sep-Dec;100(3):361-402. Riv Biol. 2007. PMID: 18278738 Review.
Cited by
-
Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma.Commun Biol. 2023 Dec 21;6(1):1292. doi: 10.1038/s42003-023-05668-3. Commun Biol. 2023. PMID: 38129585 Free PMC article.
-
Time-dependent saddle-node bifurcation: Breaking time and the point of no return in a non-autonomous model of critical transitions.Physica D. 2019 Aug;395:7-14. doi: 10.1016/j.physd.2019.02.005. Epub 2019 Feb 19. Physica D. 2019. PMID: 31700198 Free PMC article.
-
Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences.Mol Cancer Ther. 2021 Dec;20(12):2585-2597. doi: 10.1158/1535-7163.MCT-20-0547. Epub 2021 Aug 31. Mol Cancer Ther. 2021. PMID: 34465594 Free PMC article.
-
Exploring tumor-normal cross-talk with TranNet: role of the environment in tumor progression.bioRxiv [Preprint]. 2023 Feb 24:2023.02.24.529899. doi: 10.1101/2023.02.24.529899. bioRxiv. 2023. Update in: PLoS Comput Biol. 2023 Sep 18;19(9):e1011472. doi: 10.1371/journal.pcbi.1011472. PMID: 36945455 Free PMC article. Updated. Preprint.
-
Exploring tumor-normal cross-talk with TranNet: Role of the environment in tumor progression.PLoS Comput Biol. 2023 Sep 18;19(9):e1011472. doi: 10.1371/journal.pcbi.1011472. eCollection 2023 Sep. PLoS Comput Biol. 2023. PMID: 37721939 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources